SEARCH

SEARCH BY CITATION

References

  • 1
    Young, L. S.andRickinson, A. B., Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 2004. 4: 757768.
  • 2
    Dreyfus, D. H., Autoimmune disease: a role for new anti-viral therapies? Autoimmun. Rev. 2011. 11: 8897.
  • 3
    Odumade, O. A., Hogquist, K. A.andBalfour, H. H., Jr., Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin. Microbiol. Rev. 2011. 24: 193209.
  • 4
    Zhang, L.andPagano, J. S., IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell Biol. 1997. 17: 57485757.
  • 5
    Spriggs, M. K., Armitage, R. J., Comeau, M. R., Strockbine, L., Farrah, T., Macduff, B., Ulrich, D. et al., The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol. 1996. 70: 55575563.
  • 6
    Savard, M., Belanger, C., Tardif, M., Gourde, P., Flamand, L.andGosselin, J., Infection of primary human monocytes by Epstein-Barr virus. J. Virol. 2000. 74: 26122619.
  • 7
    Borza, C. M.andHutt-Fletcher, L. M., Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 2002. 8: 594599.
  • 8
    Beaulieu, A. D., Paquin, R.andGosselin, J., Epstein-Barr virus modulates de novo protein synthesis in human neutrophils. Blood 1995. 86: 27892798.
  • 9
    Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M. et al., Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 2004. 34: 796805.
  • 10
    Swiecki, M.andColonna, M., Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 2010. 234: 142162.
  • 11
    Gilliet, M., Cao, W.andLiu, Y. J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008. 8: 594606.
  • 12
    Lim, W. H., Kireta, S., Russ, G. R.andCoates, P. T., Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 2007. 109: 10431050.
  • 13
    Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B. et al., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 2005. 202: 11311139.
  • 14
    Quan, T. E., Roman, R. M., Rudenga, B. J., Holers, V. M.andCraft, J. E., Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum. 2010. 62: 16931701.
  • 15
    Fiola, S., Gosselin, D., Takada, K.andGosselin, J., TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 2010. 185: 36203631.
  • 16
    Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T.andTakada, K., EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 2006. 25: 42074214.
  • 17
    Hochrein, H., Schlatter, B., O'Keeffe, M., Wagner, C., Schmitz, F., Schiemann, M., Bauer, S. et al., Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 2004. 101: 1141611421.
  • 18
    Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S.andReise Sousa, C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004. 303: 15291531.
  • 19
    Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N.andIwasaki, A., Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007. 315: 13981401.
  • 20
    Oh, J. E.andLee, H. K., Modulation of pathogen recognition by autophagy. Front Immunol. 2012. 3: 44.
  • 21
    Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B.andHutt-Fletcher, L. M., Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 1997. 71: 46574662.
  • 22
    Gibson, S. J., Lindh, J. M., Riter, T. R., Gleason, R. M., Rogers, L. M., Fuller, A. E., Oesterich, J. L. et al., Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol. 2002. 218: 7486.
  • 23
    Collins, M., Ling, V.andCarreno, B. M., The B7 family of immune-regulatory ligands. Genome Biol. 2005. 6: 223.
  • 24
    Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. et al., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 12571266.
  • 25
    Kim, H. K., Guan, H., Zu, G., Li, H., Wu, L., Feng, X., Elmets, C. et al., High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. J. Leukoc. Biol. 2006. 79: 686695.
  • 26
    Ito, T., Yang, M., Wang, Y. H., Lande, R., Gregorio, J., Perng, O. A., Qin, X. F. et al., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007. 204: 105115.
  • 27
    Shoji-Kawata, S.andLevine, B., Autophagy, antiviral immunity, and viral countermeasures. Biochim. Biophys. Acta 2009. 1793: 14781484.
  • 28
    Guerreiro-Cacais, A. O., Li, L., Donati, D., Bejarano, M. T., Morgan, A., Masucci, M. G., Hutt-Fletcher, L. et al., Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J. Gen. Virol. 2004. 85: 27672778.
  • 29
    Chesnokova, L. S., Nishimura, S. L.andHutt-Fletcher, L. M., Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc. Natl. Acad. Sci. USA 2009. 106: 2046420469.
  • 30
    Janssen, O.andKabelitz, D., Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus. J. Immunol. 1988. 140: 125130.
  • 31
    Gosselin, J., Menezes, J., D'Addario, M., Hiscott, J., Flamand, L., Lamoureux, G.andOth, D., Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur. J. Immunol. 1991. 21: 203208.
  • 32
    Palucka, A. K., Blanck, J. P., Bennett, L., Pascual, V.andBanchereau, J., Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc. Natl. Acad. Sci. USA 2005. 102: 33723377.
  • 33
    Salek-Ardakani, S., Lyons, S. A.andArrand, J. R., Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alpha. J. Immunol. 2004. 173: 321331.
  • 34
    Jaehn, P. S., Zaenker, K. S., Schmitz, J.andDzionek, A., Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Eur. J. Immunol. 2008. 38: 18221832.
  • 35
    Castellaneta, A., Sumpter, T. L., Chen, L., Tokita, D.andThomson, A. W., NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J. Immunol. 2009. 183: 69226932.
  • 36
    Abe, M., Wang, Z., de Creus, A.andThomson, A. W., Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 2005. 5: 18081819.
  • 37
    Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 10271034.
  • 38
    Remoli, M. E., Gafa, V., Giacomini, E., Severa, M., Lande, R.andCoccia, E. M., IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur. J. Immunol. 2007. 37: 34993508.
  • 39
    Lande, R., Gafa, V., Serafini, B., Giacomini, E., Visconti, A., Remoli, M. E., Severa, M. et al., Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J. Neuropathol. Exp. Neurol. 2008. 67: 388401.
  • 40
    Delecluse, H. J., Hilsendegen, T., Pich, D., Zeidler, R.andHammerschmidt, W., Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. USA 1998. 95: 82458250.
  • 41
    Feederle, R., Mehl-Lautscham, A. M., Bannert, H.andDelecluse, H. J., The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J. Virol. 2009. 83: 1087710891.
  • 42
    Vescovo, T., Romagnoli, A., Perdomo, A. B., Corazzari, M., Ciccosanti, F., Alonzi, T., Nardacci, R. et al., Autophagy protects cells from HCV-induced defects in lipid metabolism. Gastroenterology 2012. 142: 644653.
  • 43
    Serafini, B., Severa, M., Columba-Cabezas, S., Rosicarelli, B., Veroni, C., Chiappetta, G., Magliozzi, R. et al., Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 2010. 69: 677693.